MARSHALL WACE, LLP - JUNO THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 243 filers reported holding JUNO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.

Links
Filings
External links
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$354,000
-66.9%
7,754
-78.3%
0.02%
-68.1%
Q2 2017$1,071,000
+73.6%
35,687
+120.3%
0.05%
+683.3%
Q1 2016$617,000
-81.1%
16,202
-74.1%
0.01%
-86.0%
Q4 2014$3,264,000–62,514–0.04%–
 Download
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders